Senior Vice President
Certara
David Y. Mitchell, PhD, has over 30 years experience in clinical development, strategic drug development, and project leadership. Dr. Mitchell earned his PhD in pharmaceutical sciences from the University of Colorado and completed a postdoctoral fellowship in the Department of Pharmacology, Toxicology, and Therapeutics at the University of Kansas School of Medicine.
Dr. Mitchell has led clinical pharmacology programs at Pfizer and Procter & Gamble Pharmaceuticals in the areas of oncology, neuroscience, and bone disease, and has served as a global team leader at Pfizer, OSI Pharmaceuticals, and Array Biopharma in the areas of oncology and neuroscience. Since 2009, Dr. Mitchell has been a consultant in the area of clinical pharmacology for small and large pharma and biotech companies. He is currently a senior vice president at Certara, and was the former chief scientific officer at Nuventra Pharma Sciences. He has published more than 85 manuscripts, book chapters, and abstracts on pharmacokinetics, pharmacodynamics, metabolism, toxicology, and epidemiology, and is a co-inventor on a number of patents.
Dr. Mitchell is a past president and former board member of AAPS and ASCPT, and has served as a committee chair or volunteer in other roles for both associations during the last 28 years.
Disclosure information not submitted.
Monday, October 17, 2022
9:00 AM – 10:00 AM ET